Events
CASSS Regional Forum:
Pandemic-paced CMC Development
October 21
Join us for the presentation:
Accelerating process development through outsourcing
Steve Lang, Ph.D., VP Biologics
What our customers are saying…
…the data they have generated has been used in regulatory filings to enable clinical trials and has informed our clinical indications…
Hector M Rodriguez, PhD, Hector M Rodriguez, previously head of Analytical Biochemistry, Arresto Biosciences. Currently VP of Biology, BridgeBio Pharma
News/
Press Releases
Monopar and NorthStar Partner with Aragen for Testing of Novel Potential Therapeutic for Severe COVID-19
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial Manufacturing
COVID-19 update to our customers from Axel Schleyer, CEO
Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia
Aragen Bioscience announces the appointment of Steven Lang, PhD, MBA as Vice President, Biologics